Therefore, diverse biological functions, such as immune recognition and inflammatory response, can be effectively regulated by SYK, and SYK is also considered as a novel therapy target in lots of non-hematopoietic diseases (e.g. liver fibrosis, lung cancer, and diabetic cardiomyopathy) [5, 6, 7]. The gene discussed is SYK; the disease is lung carcinoma.